A Happy Tear Shed For Virus Efficacy
Sam Fazeli, Senior Healthcare Analyst, Bloomberg Intelligence
Pfizer may be the first drugmaker to file for US regulatory authorization for its Covid-19 vaccine, which it says is 95% effective with no serious side effects. This comes right on the heels of news out of Moderna, which says its vaccine also stands at over 94%. With hopes rising that we may see a vaccine in distribution by the end of the year, we speak to Sam Fazeli, Senior Healthcare Analyst at Bloomberg Intelligence, about whether this is truly a cause for excitement.
Image Credit: Shutterstock
Produced by: Dayana Mustak
Presented by: Lyn Mak, Roshan Kanesan, Wong Shou Ning
Download the BFM mobile app. Stay at home and stay up-to-date.